RAND兰德：2024年粪便微生物群移植治疗复发性艰难梭菌感染-临床实践和医疗保健系统的挑战和改进机会报告（英文版）

Faecal microbiota transplantation (FMT) has emerged as a treatment option for C. difficile infection (CDI), the most common nosocomial bacterial infection, which can lead to intestinal damage, sepsis and even death. [1,2] While there is evidence that FMT is clinically effective for the treatment of recurrent CDI, there is a limited understanding of the diverse requirements for safe, effective, accessible and sustainable delivery of services.